Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.722. It has been cited 122 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.722
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →UK Research and Innovation
Grant: MC_PC_19055
nCoV: Rapid Clinical Development of ChAdOx1 nCoV-19
National Institutes of Health
Grant: 5R21TW011454-02
Rational structure-guided design of broadly reactive next-generation therapeutics to treat non-communicable snakebite in Africa
Fields of Study
Sustainable Development Goals